تسجيل الدخول/ اشتراك

Novo Nordisk shares fell, wiping away the last gains Wegovy's launch had brought, after the drugmaker said its next-generation obesity drug CagriSema underperformed Eli Lilly's tirzepatide in a trial

٢٣/٠٢ ٢٢:١٥
صاعد
سبحة

الأخبار الشائعة